{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:11:45Z","timestamp":1793293905622,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"CytoSorbents SA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cytokine hemoadsorption might be beneficial in patients with sepsis. However, its effect on anti-infective agents' disposition remains largely unknown. We sought to determine the influence of hemoadsorption on the pharmacokinetics of common anti-infective agents. This is an interventional experimental study, conducted in 24 healthy pigs. Animals were randomly allocated to either hemoadsorption (cases) or sham extracorporeal circuit (controls) and to drug combinations (3 cases and 3 controls for each combination). Hemoadsorption was performed with CytoSorb (CytoSorbents Corporation, USA). We evaluated 17 drugs (clindamycin, fluconazole, linezolid, meropenem, piperacillin, anidulafungin, ganciclovir, clarithromycin, posaconazole, teicoplanin, tobramycin, ceftriaxone, ciprofloxacin, metronidazole, liposomal amphotericin B, flucloxacillin and cefepime). Repeated blood sampling from the extracorporeal circulation (adsorber inlet\/outlet, sham circuit) was performed over six hours following administration. Total clearance and adsorber-specific clearance were computed. Hemoadsorption was associated with increased clearance of all study drugs, except ganciclovir. Its impact on total body clearance was considered as moderate for fluconazole (282%) and linezolid (115%), mild for liposomal amphotericin B (75%), posaconazole (32%) and teicoplanine (31%) and negligible for all other drugs. Hemoadsorber clearance declined over time, with even delayed desorption for beta-lactams. It was moderately correlated with drug's lipophilicity (p\u2009=\u20090.01; r\n                    <jats:sup>2<\/jats:sup>\n                    \u2009=\u20090.43). Hemoadsorption with CytoSorb appears to increase to a clinically significant extent the clearance of five among 17 tested anti-infectives. Studies in human patients are required to confirm the need for dosage adjustment of these agents.\n                  <\/jats:p>","DOI":"10.1038\/s41598-021-89965-z","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T06:06:23Z","timestamp":1621317983000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Pharmacokinetics of anti-infective agents during CytoSorb hemoadsorption"],"prefix":"10.1038","volume":"11","author":[{"given":"Antoine G.","family":"Schneider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg","family":"Scheier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Ziervogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Buclin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlef","family":"Kindgen-Milles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,18]]},"reference":[{"key":"89965_CR1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd, K. E. et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: Analysis for the Global Burden of Disease Study. Lancet 395, 200\u2013211. https:\/\/doi.org\/10.1016\/S0140-6736(19)32989-7 (2020).","journal-title":"Lancet"},{"key":"89965_CR2","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer, M. et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315, 801\u2013810. https:\/\/doi.org\/10.1001\/jama.2016.0287 (2016).","journal-title":"JAMA"},{"key":"89965_CR3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1128\/MMBR.05015-11","volume":"76","author":"JR Tisoncik","year":"2012","unstructured":"Tisoncik, J. R. et al. Into the eye of the cytokine storm. Microbiol. Mol. Biol. Rev. 76, 16\u201332. https:\/\/doi.org\/10.1128\/MMBR.05015-11 (2012).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"89965_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-018-5464-6","author":"EC Poli","year":"2018","unstructured":"Poli, E. C., Rimmele, T. & Schneider, A. G. Hemoadsorption with CytoSorb((R)). Intensive Care Med. https:\/\/doi.org\/10.1007\/s00134-018-5464-6 (2018).","journal-title":"Intensive Care Med."},{"key":"89965_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/cc9411","volume":"15","author":"T Rimmel\u00e9","year":"2011","unstructured":"Rimmel\u00e9, T. & Kellum, J. A. Clinical review: Blood purification for sepsis. Crit. Care 15, 205\u2013205. https:\/\/doi.org\/10.1186\/cc9411 (2011).","journal-title":"Crit. Care"},{"key":"89965_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40635-018-0177-2","volume":"6","author":"B Malard","year":"2018","unstructured":"Malard, B., Lambert, C. & Kellum, J. A. In vitro comparison of the adsorption of inflammatory mediators by blood purification devices. Intensive Care Med. Exp. 6, 12. https:\/\/doi.org\/10.1186\/s40635-018-0177-2 (2018).","journal-title":"Intensive Care Med. Exp."},{"key":"89965_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s00063-017-0342-5","author":"S Friesecke","year":"2017","unstructured":"Friesecke, S. et al. International registry on the use of the CytoSorb\u00ae adsorber in ICU patients. Med. Klin. https:\/\/doi.org\/10.1007\/s00063-017-0342-5 (2017).","journal-title":"Med. Klin."},{"key":"89965_CR8","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s10047-017-0967-4","volume":"20","author":"S Friesecke","year":"2017","unstructured":"Friesecke, S., Stecher, S.-S., Gross, S., Felix, S. B. & Nierhaus, A. Extracorporeal cytokine elimination as rescue therapy in refractory septic shock: A prospective single-center study. J. Artif. Organs 20, 252\u2013259. https:\/\/doi.org\/10.1007\/s10047-017-0967-4 (2017).","journal-title":"J. Artif. Organs"},{"key":"89965_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13054-017-1662-9","volume":"21","author":"K Kogelmann","year":"2017","unstructured":"Kogelmann, K., Jarczak, D., Scheller, M. & Dr\u00fcner, M. Hemoadsorption by CytoSorb in septic patients: A case series. Crit. Care 21, 74. https:\/\/doi.org\/10.1186\/s13054-017-1662-9 (2017).","journal-title":"Crit. Care"},{"key":"89965_CR10","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s13054-019-2588-1","volume":"23","author":"WP Brouwer","year":"2019","unstructured":"Brouwer, W. P., Duran, S., Kuijper, M. & Ince, C. Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: A propensity-score-weighted retrospective study. Crit. Care 23, 317. https:\/\/doi.org\/10.1186\/s13054-019-2588-1 (2019).","journal-title":"Crit. Care"},{"key":"89965_CR11","doi-asserted-by":"publisher","first-page":"e0187015","DOI":"10.1371\/journal.pone.0187015","volume":"12","author":"D Schadler","year":"2017","unstructured":"Schadler, D. et al. The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: A randomized controlled trial. PLoS ONE 12, e0187015. https:\/\/doi.org\/10.1371\/journal.pone.0187015 (2017).","journal-title":"PLoS ONE"},{"key":"89965_CR12","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","volume":"45","author":"A Rhodes","year":"2017","unstructured":"Rhodes, A. et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016. Crit. Care Med. 45, 486\u2013552. https:\/\/doi.org\/10.1097\/CCM.0000000000002255 (2017).","journal-title":"Crit. Care Med."},{"key":"89965_CR13","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1159\/000063108","volume":"20","author":"K Reiter","year":"2002","unstructured":"Reiter, K. et al. In vitro removal of therapeutic drugs with a novel adsorbent system. Blood Purif. 20, 380\u2013388. https:\/\/doi.org\/10.1159\/000063108 (2002).","journal-title":"Blood Purif."},{"key":"89965_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/0391398818812601","volume":"42","author":"C Konig","year":"2019","unstructured":"Konig, C. et al. In vitro removal of anti-infective agents by a novel cytokine adsorbent system. Int. J. Artif. Organs 42, 57\u201364. https:\/\/doi.org\/10.1177\/0391398818812601 (2019).","journal-title":"Int. J. Artif. Organs"},{"key":"89965_CR15","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1093\/jac\/dkv068","volume":"70","author":"M Zoller","year":"2015","unstructured":"Zoller, M. et al. Can cytokine adsorber treatment affect antibiotic concentrations? A case report. J. Antimicrob. Chemother. 70, 2169\u20132171. https:\/\/doi.org\/10.1093\/jac\/dkv068 (2015).","journal-title":"J. Antimicrob. Chemother."},{"key":"89965_CR16","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1177\/0391398819831303","volume":"42","author":"EC Poli","year":"2019","unstructured":"Poli, E. C. et al. Clindamycin clearance during Cytosorb((R)) hemoadsorption: A case report and pharmacokinetic study. Int. J. Artif. Organs 42, 258\u2013262. https:\/\/doi.org\/10.1177\/0391398819831303 (2019).","journal-title":"Int. J. Artif. Organs"},{"key":"89965_CR17","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1177\/0391398820917151","volume":"43","author":"T Dimski","year":"2020","unstructured":"Dimski, T., Brandenburger, T., MacKenzie, C. & Kindgen-Milles, D. Elimination of glycopeptide antibiotics by cytokine hemoadsorption in patients with septic shock: A study of three cases. Int. J. Artif. Organs 43, 753\u2013757. https:\/\/doi.org\/10.1177\/0391398820917151 (2020).","journal-title":"Int. J. Artif. Organs"},{"key":"89965_CR18","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/jcbfm.2010.220","volume":"31","author":"C Kilkenny","year":"2011","unstructured":"Kilkenny, C. et al. Animal research: Reporting in vivo experiments: The ARRIVE guidelines. J. Cereb. Blood Flow Metab. 31, 991\u2013993. https:\/\/doi.org\/10.1038\/jcbfm.2010.220 (2011).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"89965_CR19","unstructured":"European_Medicine_Agency. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-investigation-drug-interactions-revision-1_en.pdf. (2012)."},{"key":"89965_CR20","unstructured":"ChemAxon. (https:\/\/chemaxon.com\/products\/chemicalize)"},{"key":"89965_CR21","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1177\/1751143715574855","volume":"16","author":"C Morris","year":"2015","unstructured":"Morris, C., Gray, L. & Giovannelli, M. Early report: The use of Cytosorb haemabsorption column as an adjunct in managing severe sepsis: Initial experiences, review and recommendations. J. Intensive Care Soc. 16, 257\u2013264. https:\/\/doi.org\/10.1177\/1751143715574855 (2015).","journal-title":"J. Intensive Care Soc."},{"key":"89965_CR22","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1093\/jac\/dkn102","volume":"61","author":"N Perrottet","year":"2008","unstructured":"Perrottet, N. et al. Disposition of valganciclovir during continuous renal replacement therapy in two lung transplant recipients. J. Antimicrob. Chemother. 61, 1332\u20131335. https:\/\/doi.org\/10.1093\/jac\/dkn102 (2008).","journal-title":"J. Antimicrob. Chemother."},{"key":"89965_CR23","doi-asserted-by":"publisher","first-page":"1905871","DOI":"10.1155\/2019\/1905871","volume":"2019","author":"N De Schryver","year":"2019","unstructured":"De Schryver, N., Hantson, P., Haufroid, V. & Dechamps, M. Cardiogenic Shock In A Hemodialyzed Patient On Flecainide: Treatment with intravenous fat emulsion, extracorporeal cardiac life support, and CytoSorb(R) hemoadsorption. Case Rep. Cardiol. 2019, 1905871. https:\/\/doi.org\/10.1155\/2019\/1905871 (2019).","journal-title":"Case Rep. Cardiol."},{"key":"89965_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40635-020-00313-3","volume":"8","author":"CN Lang","year":"2020","unstructured":"Lang, C. N. et al. Use of the CytoSorb adsorption device in MDMA intoxication: A first-in-man application and in vitro study. Intensive Care Med. Exp. 8, 21. https:\/\/doi.org\/10.1186\/s40635-020-00313-3 (2020).","journal-title":"Intensive Care Med. Exp."},{"key":"89965_CR25","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.3390\/polym12051114","volume":"12","author":"P Franco","year":"2020","unstructured":"Franco, P. & De Marco, I. The use of poly(N-vinyl pyrrolidone) in the delivery of drugs: A review. Polymers (Basel) 12, 1114. https:\/\/doi.org\/10.3390\/polym12051114 (2020).","journal-title":"Polymers (Basel)"},{"key":"89965_CR26","volume-title":"Goodman & Gilman's Pharmacological Basis of Therapeutics","author":"L Goodman","year":"2011","unstructured":"Goodman, L., Brunton, L., Chabner, B. & Knollmann, C. Goodman & Gilman\u2019s Pharmacological Basis of Therapeutics (McGraw-Hill, New York, 2011)."},{"key":"89965_CR27","unstructured":"Targocid_information. https:\/\/www.swissmedicinfo.ch\/Accept.aspx?Lang=EN. Swissmedicinfo (2017)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89965-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89965-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89965-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T03:34:36Z","timestamp":1670038476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89965-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,18]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["89965"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-89965-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,18]]},"assertion":[{"value":"29 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JS is Senior Director Medical & Clinical of CytoSorbents Europe. AS and DKM have received speaking honorarium from CytoSorbents Europe. All other authors stated that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10493"}}